Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.
Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, Hayward-Könnecke H, Schippling S, Rommer PS, Kornek B, Zrzavy T, Biotti D, Ciron J, Audoin B, Berthele A, Giglhuber K, Zephir H, Kümpfel T, Berger R, Röther J, Häußler V, Stellmann JP, Whittam D, Jacob A, Kraemer M, Gueguen A, Deschamps R, Bayas A, Hümmert MW, Trebst C, Haarmann A, Jarius S, Wildemann B, Grothe M, Siebert N, Ruprecht K, Paul F, Collongues N, Marignier R, Levy M, Karenfort M, Deppe M, Albrecht P, Hellwig K, Gold R, Hartung HP, Meuth SG, Kleiter I, Aktas O; Neuromyelitis Optica Study Group (NEMOS). Ringelstein M, et al. Among authors: novi g. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 16;9(1):e1100. doi: 10.1212/NXI.0000000000001100. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34785575 Free PMC article.
Tocilizumab in MOG-antibody spectrum disorder: a case report.
Novi G, Gastaldi M, Franciotta D, Pesce G, Benedetti L, Uccelli A. Novi G, et al. Mult Scler Relat Disord. 2019 Jan;27:312-314. doi: 10.1016/j.msard.2018.11.012. Epub 2018 Nov 13. Mult Scler Relat Disord. 2019. PMID: 30469022
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.
Cellerino M, Cordano C, Boffa G, Bommarito G, Petracca M, Sbragia E, Novi G, Lapucci C, Capello E, Uccelli A, Inglese M. Cellerino M, et al. Among authors: novi g. Neurol Neuroimmunol Neuroinflamm. 2019 Aug 12;6(5):e596. doi: 10.1212/NXI.0000000000000596. Print 2019 Sep. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31454778 Free PMC article.
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.
Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group. Novi G, et al. Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4. Mult Scler Relat Disord. 2019. PMID: 31610404
Acute disseminated encephalomyelitis after SARS-CoV-2 infection.
Novi G, Rossi T, Pedemonte E, Saitta L, Rolla C, Roccatagliata L, Inglese M, Farinini D. Novi G, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Jun 1;7(5):e797. doi: 10.1212/NXI.0000000000000797. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32482781 Free PMC article. No abstract available.
Cell-based assays for the detection of MOG antibodies: a comparative study.
Gastaldi M, Scaranzin S, Jarius S, Wildeman B, Zardini E, Mallucci G, Rigoni E, Vegezzi E, Foiadelli T, Savasta S, Banfi P, Versino M, Benedetti L, Novi G, Mancardi MM, Giacomini T, Annovazzi P, Baroncini D, Ferraro D, Lampasona V, Reindl M, Waters P, Franciotta D. Gastaldi M, et al. Among authors: novi g. J Neurol. 2020 Dec;267(12):3555-3564. doi: 10.1007/s00415-020-10024-0. Epub 2020 Jul 4. J Neurol. 2020. PMID: 32623596
Different MRI patterns in MS worsening after stopping fingolimod.
Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L. Lapucci C, et al. Among authors: novi g. Neurol Neuroimmunol Neuroinflamm. 2019 Apr 16;6(4):e566. doi: 10.1212/NXI.0000000000000566. eCollection 2019 Jul. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31086807 Free PMC article.
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study.
Cellerino M, Ivaldi F, Pardini M, Rotta G, Vila G, Bäcker-Koduah P, Berge T, Laroni A, Lapucci C, Novi G, Boffa G, Sbragia E, Palmeri S, Asseyer S, Høgestøl E, Campi C, Piana M, Inglese M, Paul F, Harbo HF, Villoslada P, Kerlero de Rosbo N, Uccelli A. Cellerino M, et al. Among authors: novi g. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 5;7(3):e693. doi: 10.1212/NXI.0000000000000693. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32139439 Free PMC article.
Tailoring B cell depletion therapy in MS according to memory B cell monitoring.
Novi G, Bovis F, Fabbri S, Tazza F, Gazzola P, Maietta I, Currò D, Bruschi N, Roccatagliata L, Boffa G, Lapucci C, Pesce G, Cellerino M, Solaro C, Laroni A, Capello E, Mancardi G, Sormani M, Inglese M, Uccelli A. Novi G, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Aug 4;7(5):e845. doi: 10.1212/NXI.0000000000000845. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32753406 Free PMC article.
88 results